β-Funaltrexamine

Chemical structure of β-Funaltrexamine

β-Funaltrexamine (β-FNA) is a potent and selective opioid receptor antagonist, primarily targeting the mu-opioid receptor (MOR). It is a derivative of naltrexone, modified to enhance its binding affinity and selectivity for the MOR, making it a valuable tool in pharmacology and neuroscience research.

Chemical Properties

β-Funaltrexamine is a synthetic compound with a complex chemical structure that includes a morphinan backbone. The presence of a furan ring in its structure is a distinguishing feature that contributes to its high affinity for the mu-opioid receptor. The chemical formula of β-FNA is C29H35NO4, and it has a molecular weight of 461.6 g/mol.

Mechanism of Action

β-Funaltrexamine acts as an irreversible antagonist at the mu-opioid receptor. It binds covalently to the receptor, leading to a long-lasting blockade of receptor activity. This irreversible binding is achieved through the formation of a covalent bond between the furan ring of β-FNA and a nucleophilic site on the receptor, typically involving a cysteine residue. This mechanism makes β-FNA particularly useful for studying the long-term effects of mu-opioid receptor inhibition.

Pharmacological Effects

As an irreversible antagonist, β-Funaltrexamine is used to study the role of mu-opioid receptors in various physiological and pathological processes. It is often employed in animal models to investigate the effects of opioid receptor blockade on pain perception, addiction, and tolerance. The long-lasting nature of its action allows researchers to examine the consequences of sustained receptor inhibition without the need for continuous drug administration.

Applications in Research

β-Funaltrexamine is widely used in preclinical research to explore the function of mu-opioid receptors in the central nervous system. It has been instrumental in elucidating the mechanisms underlying opioid-induced analgesia, euphoria, and respiratory depression. Additionally, β-FNA is used to study the development of opioid tolerance and dependence, providing insights into potential therapeutic strategies for opioid use disorder.

Safety and Handling

As with many research chemicals, β-Funaltrexamine should be handled with care. It is important to use appropriate personal protective equipment and follow safety protocols to prevent exposure. Due to its potent pharmacological activity, β-FNA should only be used in controlled laboratory settings by trained personnel.

Related Pages

• Opioid receptor
• Mu-opioid receptor
• Naltrexone
• Opioid antagonist
• Pharmacology